A biodegradable polyester technology that integrates aryl pendant groups into polycaprolactone to improve water barrier performance while retaining compostability and melt-processability. Designed for sustainable packaging, agricultural films, and other applications where moisture resistance and environmental degradability are both required.
This research proposes a new class of aryl-functionalized caprolactone polyesters designed to deliver significantly improved water barrier performance compared to conventional polycaprolactone, without sacrificing biodegradability or ease of processing. By incorporating aryl pendant groups into the polymer backbone, the material gains higher crystallinity, an elevated glass transition temperature, and greater surface hydrophobicity. Because the aryl groups can be chemically modified, barrier and mechanical properties can be tuned to match specific end-use requirements. The ester linkages in the main chain remain enzymatically cleavable, enabling degradation under industrial composting conditions and supporting circular-economy and sustainability goals.
Material design and synthesis:
Performance targets and rationale:
Characterization methods:
The technology is at an early-stage, concept-validation phase. The working hypothesis is grounded in published precedent showing that phenyl pendant groups enhance crystallization rate and raise glass transition temperature. Planned work covers monomer synthesis, polymerization, thermal and barrier characterization, and compostability evaluation. The program is positioned to produce benchmark data on water barrier performance and degradation behavior to determine commercial viability.
UNC–Chapel Hill is a comprehensive public research university and the state’s flagship, pairing broad academic depth with a major academic health system. Industry partners access co‑located core facilities, sponsored research, and an on‑campus innovation hub that connects companies to faculty and advanced instrumentation. Integration with a major hospital system and statewide clinics enables patient access, clinical trials, and real‑world evidence collaborations. Minutes from Research Triangle Park, the university works within a dense corporate R&D ecosystem. Research is supported by strong competitive federal funding, including NIH and NSF, and a dedicated technology transfer office streamlines IP, licensing, MTAs, and startup formation.